Flat ₹100 OFF on First app order | Use Code: APP100 |
Flat ₹100 OFF
on First app order
Use Code
APP100
Download Now
Salt CompositionTacrolimus 0.1% w/v
Tacvido Forte Oral Gel
You Searched
Tacvido Forte Oral Gel
Mohrish Pharmaceuticals
₹690
WHO GMP
Certified
15 Days Easy
Returns
Long Expiry
(>8 Months)
WHO GMP
Certified
15 Days Easy
Returns
Long Expiry
(>8 Months)
Used In
Oral lichen planus
Customers also bought
More About Tacvido
Benefits
In Oral lichen planus Tacvido Forte Oral Gel belongs to a group of medicines known as immunosuppressive agents. It helps relieve inflammation associated with oral lichen planus. This medicine works by decreasing the production of certain chemicals that cause inflammation. Do not eat or drink for at least 30 minutes after application. Use it as prescribed to get the most benefit. If you see no improvement even after a week, talk to your doctor.
Side Effects
The majority of side effects typically do not necessitate medical intervention. and disappear as your body adjusts to the medicine. Doctor consultation is advised if they persist or if you're worried about them.
How to use
This medicine is for external use only. Use this medicine in the dose and duration as advised by your doctor.
How it works
Tacvido Forte Oral Gel is an immunosuppressant. It works by blocking calcineurin, an enzyme that activates T lymphocytes and causes inflammation associated with lichen planus.
No interaction has been found or established.
Seek medical advice from your doctor: Tacvido Forte Oral Gel may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Doctor consultation is advised.
Safe when prescribed by an expert: Tacvido Forte Oral Gel is probably safe to use during breastfeeding. Limited human data suggests that the drug does not represent any significant risk to the baby.
No interaction found/established
No interaction found/established
No interaction found/established
Manufacturer Address
59/1, First Floor, Kalu Sarai, Aurobindo Marg, New Delhi - 110016
References
Burkhart C, Morrell D, Goldsmith L. Dermatological Pharmacology. In: Brunton LL, Chabner BA, Knollmann BC, editors. Goodman & Gilmans: The Pharmacological Basis of Therapeutics. 12th ed. New York, New York: McGraw-Hill Medical; 2011. p. 1822
Lake DF, Briggs AD, Akporiaye ET. Immunopharmacology. In: Katzung BG, Masters SB, Trevor AJ, editors. Basic and Clinical Pharmacology. 11th ed. New Delhi, India: Tata McGraw Hill Education Private Limited; 2009. p. 972
Briggs GG, Freeman RK, editors. A Reference Guide to Fetal and Neonatal Risk: Drugs in Pregnancy and Lactation. 10th ed. Philadelphia, PA: Wolters Kluwer Health; 2015. pp. 1305-309
Resende JP, Chaves Md, Aarestrup FM, et al. Oral lichen planus treated with tacrolimus 0.1%. Int J Clin Exp Med. 2013 Oct 25;6(10):917-21 (01 Aug. 2023)
Sun SL, Liu JJ, Zhong B, et al. Topical calcineurin inhibitors in the treatment of oral lichen planus: a systematic review and meta-analysis. Br J Dermatol. 2019 Dec;181(6):1166-1176 (06 Aug. 2023)
Disclaimer
PlatinumRx is dedicated to delivering dependable and trustworthy information to empower our customers. However, the information presented here is solely for general informational purposes and should not be utilized for diagnosing, preventing, or treating health issues. It is not intended to establish a doctor-patient relationship or serve as a substitute for professional medical advice.
